For the Quarter Ending June 2026
Bupropion Prices in North America
- In United States, the Bupropion Price Index rose quarter-over-quarter in Q2 2026, driven by elevated producer inflation in June 2026.
- Bupropion production costs increased in Q2 2026, influenced by a 5.5% year-over-year rise in producer prices in June 2026.
- Demand for Bupropion was supported by a healthy 4.2% unemployment rate in June 2026, despite slower prescription medicine growth.
- Elevated consumer inflation, with CPI rising 3.5% year-over-year in June 2026, impacted Bupropion purchasing power.
- Naphtha costs, a key feedstock, surged into April 2026 but fell through June 2026, easing production expenses.
- The Pharmaceuticals sector experienced market expansion in Q2 2026, supporting overall demand for therapies.
- Sluggish industrial production growth of 0.7% year-over-year in June 2026 indicated a weaker economic environment.
- Robust retail sales growth of 6.9% year-over-year in May 2026 indicated strong consumer financial health.
- Geopolitical conflicts disrupted global chemical supply chains in Q2 2026, impacting imports, easing in June 2026.
Why did the price of Bupropion change in June 2026 in North America?
- Producer prices rose 5.5% year-over-year in June 2026, increasing Bupropion manufacturing costs.
- Naphtha and crude oil feedstock costs fell through June 2026, easing production pressures.
- Consumer purchasing power impacted by 3.5% year-over-year CPI inflation in June 2026.
-
Bupropion Prices in APAC
- In China, the Bupropion Price Index rose quarter-over-quarter in Q2 2026, driven by increasing production costs.
- Bupropion prices were assessed at USD 75,000/MT India.
- Bupropion production costs increased in Q2 2026, as the Producer Price Index rose 4.1% in June 2026.
- Demand for Bupropion was supported by steady growth in China's pharmaceutical market during Q2 2026.
- Aromatic hydrocarbon feedstock costs were robust in China during Q2 2026, impacting manufacturing expenses.
- Feedstock availability tightened for Asian chemical producers in Q2 2026, elevating naphtha and butane costs in May.
- China's Industrial Production grew 5.3% in June 2026, indicating a supportive economic environment.
- The Manufacturing Index expanded in June 2026, reflecting a healthy industrial base for supply chains.
- Bupropion demand outlook was tempered by weak retail sales growth of 1.0% in June 2026.
- Overseas buyers reduced new orders from China in May 2026 due to swelled inventories, impacting trade.
Why did the price of Bupropion change in June 2026 in APAC?
- Producer Price Index rose 4.1% in June 2026, increasing Bupropion production costs.
- Aromatic hydrocarbon feedstock costs were robust in Q2 2026, influencing Bupropion manufacturing expenses.
- Weak retail sales growth of 1.0% in June 2026 tempered Bupropion demand.
Bupropion Prices in Europe
- In Germany, the Bupropion Price Index rose quarter-over-quarter in Q2 2026, driven by increased costs and supply disruptions.
- Producer prices of industrial products increased by 2.2% year-on-year in May 2026, impacting Bupropion manufacturing expenses.
- German industrial producer prices for intermediate goods rose in June 2026, keeping upstream cost pressure.
- Consumer Price Index rose by 2.3% year-on-year in June 2026, reflecting general cost increases for manufacturers.
- Domestic sales for the German chemical and pharmaceutical sector firmed in H1 2026, supporting Bupropion demand.
- Retail sales in Germany increased by 1.8% in May 2026, indicating healthy consumer spending and affordability.
- Germany's unemployment rate remained stable at 3.8% in May 2026, supporting patient access.
- Germany's chemical and pharmaceutical sector output contracted in H1 2026, contributing to Bupropion supply constraints.
- Mineral oil product prices climbed sharply in Germany in June 2026, raising energy and feedstock costs.
- The Manufacturing Index showed a contracting trend in June 2026, signaling broader economic weakness.
Why did the price of Bupropion change in June 2026 in Europe?
- Industrial producer prices for intermediate goods rose in June 2026, increasing manufacturing costs.
- Raw material shortages challenged German chemical firms in April 2026, impacting production.
- Mineral oil product prices climbed sharply in June 2026, raising energy and feedstock expenses.
For the Quarter Ending March 2026
Bupropion Prices in North America
- In United States, the Bupropion Price Index rose quarter-over-quarter in Q1 2026, driven by elevated intermediate chemical costs.
- The Bupropion Production Cost Trend increased in March 2026 as the Producer Price Index rose 4.0 percent.
- Consumer inflation rose 3.3 percent year-over-year in March 2026, increasing transportation expenses for the Bupropion Price Index.
- The Bupropion Demand Outlook remained robust in March 2026, supported by retail sales growing 4.0 percent year-over-year.
- A stable 4.3 percent unemployment rate in March 2026 ensured health insurance access, supporting steady Bupropion consumption.
- Industrial production grew 0.7 percent year-over-year in March 2026, ensuring adequate domestic manufacturing capabilities for Bupropion synthesis.
- The Manufacturing Index expanded in March 2026, indicating stable supply chains for chemical reagents needed for Bupropion.
- Producer prices for primary basic organic chemicals used in Bupropion synthesis increased significantly in March 2026.
- Final demand for pharmaceutical preparations stabilized in March 2026, reinforcing a consistent Bupropion Price Forecast trend.
Why did the price of Bupropion change in March 2026 in North America?
- Processed energy goods costs for intermediate chemical demand jumped sharply across the region in March 2026.
- Natural gas spot prices spiked briefly in late January 2026 due to extreme winter weather.
- Producer prices for primary basic organic chemicals increased steadily during the quarter ending March 2026.
Bupropion Prices in APAC
- In China, the Bupropion Price Index rose quarter-over-quarter in Q1 2026, driven by surging bromine feedstock costs.
- The Bupropion Production Cost Trend increased during Q1 2026 as factory-gate prices rose 0.5% in March 2026.
- The Bupropion Demand Outlook strengthened in Q1 2026, supported by a 1.0% consumer inflation rate in March 2026.
- The Bupropion Price Forecast remained elevated in Q1 2026 as the Manufacturing Index expanded in March 2026.
- Industrial production grew 5.7% in March 2026, providing strong base chemical output for Bupropion in Q1 2026.
- Retail sales grew 1.7% in March 2026, showing softer spending on elective Bupropion prescriptions in Q1 2026.
- Unemployment reached 5.4% in March 2026, driving clinical need for Bupropion antidepressants during Q1 2026.
- Consumer confidence hit 91.6 in February 2026, reducing spending on Bupropion smoking cessation programs in Q1 2026.
- Bupropion API exports accelerated in Q1 2026 due to increased international procurement of Chinese intermediates in Q1 2026.
Why did the price of Bupropion change in March 2026 in APAC?
- Bromine feedstock costs for Bupropion synthesis surged significantly amid contracted domestic supply in Q1 2026.
- Domestic pharmaceutical requirements for Bupropion APIs surged following record outbound licensing deals in Q1 2026.
- Elevated sulfur raw material costs further pressured Bupropion production expenses throughout the Q1 2026 period.
Bupropion Prices in Europe
- In Germany, the Bupropion Price Index rose quarter-over-quarter in Q1 2026, driven by surging propylene feedstock costs.
- The Bupropion Production Cost Trend increased in March 2026 as 2.7% consumer inflation elevated operational expenses.
- Despite producer prices declining 0.2% in March 2026, the Bupropion Demand Outlook remained robust for exports.
- The Bupropion Price Forecast reflected upward revisions in March 2026 after the Manufacturing Index expanded, tightening supply.
- Industrial production stagnated at 0.0% in February 2026, while domestic pharmaceutical manufacturing output contracted simultaneously.
- Retail sales grew 0.7% and unemployment held at 4.2% in February 2026, supporting steady prescription purchases.
- Consumer confidence dropped to -24.7 in March 2026, negatively impacting discretionary smoking cessation purchases across Germany.
- European propylene availability tightened severely in Q1 2026, and industrial natural gas consumption spiked in January 2026.
- Pharmaceutical export volumes expanded robustly in January 2026, prompting producers to build inventories throughout Q1 2026.
Why did the price of Bupropion change in March 2026 in Europe?
- Propylene feedstock costs surged to multi-year highs in Q1 2026 amid severe geopolitical supply shocks.
- Middle Eastern supply chain disruptions severely constrained upstream petrochemical availability in Europe during March 2026.
- European natural gas benchmark prices faced upward pressure in Q1 2026 amid tight market balances.
For the Quarter Ending December 2025
Bupropion Prices in North America
- In United States, the Bupropion Price Index inched up quarter-over-quarter in Q4 2025, influenced by rising consumer prices.
- Bupropion production costs faced upward pressure as PPI increased 3.0% year-over-year in November 2025.
- Bupropion demand outlook remained strong, supported by a 3.3% year-over-year increase in retail sales in November 2025.
- Organic chemical intermediate costs and US Henry Hub natural gas spot prices faced downward pressure in Q4 2025.
- The unemployment rate of 4.4% in December 2025 indicated a strong labor market, supporting healthcare access.
- Industrial production increased 2.0% year-over-year in December 2025, despite manufacturing output declining in Q4 2025.
- US pharmaceutical preparations imports decreased in October 2025, impacting overall Bupropion supply dynamics.
- Tighter capital and higher financing costs impacted the chemical industry in Q4 2025, affecting Bupropion.
Why did the price of Bupropion change in December 2025 in North America?
- Producer Price Index increased 3.0% year-over-year in November 2025, raising Bupropion manufacturing input costs.
- Retail sales increased 3.3% year-over-year in November 2025, indicating robust consumer spending supporting healthcare.
- Organic chemical intermediate costs faced downward pressure through the end of 2025, influencing Bupropion production.
Bupropion Prices in APAC
- In China, the Bupropion Price Index rose quarter-over-quarter in Q4 2025, influenced by an upward trend in manufacturing input costs.
- Bupropion production costs trended upward in Q4 2025, despite producer prices declining 1.9% year-over-year in December 2025.
- Weak consumer spending, with retail sales growing 0.9% and CPI at 0.8% in December 2025, affected Bupropion demand.
- A 5.1% unemployment rate in December 2025 indicated reduced disposable income, indirectly affecting Bupropion demand.
- China's pharmaceutical sector thrived in 2025, bolstering Bupropion demand despite moderated overall economic growth in Q4 2025.
- Manufacturing sector expanded in December 2025, industrial production grew 5.2% year-over-year, supporting supply chains.
- China's medicine exports, including chemical active pharmaceutical ingredients, steadily increased in the first 11 months of 2025.
- Raw materials inventory declined in November 2025, but companies reported sufficient inventories in December 2025.
Why did the price of Bupropion change in December 2025 in APAC?
- Manufacturing input costs accelerated in December 2025, pressuring Bupropion production expenses upward.
- Weak consumer spending, with retail sales growing 0.9% year-over-year in December 2025, tempered Bupropion demand.
- Producer prices declined 1.9% year-over-year in December 2025, indicating lower overall input costs.
Bupropion Prices in Europe
- In Germany, the Bupropion Price Index fell quarter-over-quarter in Q4 2025, influenced by reduced producer costs in December 2025.
- Bupropion production costs decreased in Q4 2025, as the Producer Price Index declined by 2.5% year-over-year in December 2025.
- Bupropion demand remained stable in Q4 2025, supported by consistent German pharmaceutical demand for high-value therapies.
- Bromine feedstock costs for Bupropion production in Europe inched down in November 2025.
- European industrial natural gas prices remained elevated in Q4 2025, impacting manufacturing expenses.
- The Manufacturing Index contracted in December 2025, indicating a slowdown in Germany's economic activity.
- Consumer confidence deteriorated to -17.5 in December 2025, dampening discretionary health spending.
- German industrial production inched up by 0.8% year-over-year in October 2025, despite overall contraction.
- Unemployment at 6.2% and CPI at 1.8% in December 2025 impacted consumer purchasing power.
Why did the price of Bupropion change in December 2025 in Europe?
- Producer Price Index declined by 2.5% year-over-year in December 2025, reducing manufacturing input costs.
- Bromine feedstock costs in Europe inched down in November 2025, lowering Bupropion production expenses.
- Contracting Manufacturing Index in December 2025 signaled weaker industrial activity and dampened demand.
For the Quarter Ending September 2025
Bupropio Prices in North America
- In United States, Bupropion Price Index rose in Q3 2025, driven by rising production costs.
- Bupropion production costs increased in Q3 2025, influenced by 2.6% PPI rise in August 2025.
- Bupropion demand supported by 5.42% retail sales increase and 4.3% unemployment in September 2025.
- Bupropion demand faced headwinds from 3.0% CPI increase and declining consumer confidence in September 2025.
- US manufacturing inventories tightened in Q3 2025; chemical inventories shrank due to destocking.
- US chemical manufacturing output contracted in Q3 2025; nondurable goods production slipped in September.
- Bupropion Price Forecast indicates upward pressure from sustained pharmaceutical intermediate demand and rising costs.
- Trade tensions and U.S. tariffs on imported chemicals impacted the market in Q3 2025, affecting supply.
- Strengthened US pharmaceutical market sentiment and drug approvals in Q3 2025 supported generic demand.
Why did the price of Bupropion change in September 2025 in North America?
- Bupropion input costs increased in Q3 2025, driven by 2.6% PPI rise in August.
- US manufacturing and chemical inventories tightened in Q3 2025, limiting Bupropion supply.
- Strong retail sales (up 5.42% in September 2025) supported Bupropion demand.
Bupropio Prices in APAC
- In China, the Bupropion Price Index remained stable in Q3 2025, influenced by mixed macroeconomic signals.
- Bupropion production costs declined in Q3 2025, as PPI fell by 2.3% in September 2025, reducing factory-gate prices.
- Bupropion demand outlook was tempered by pessimistic consumer confidence, recorded at 89.6 in September 2025.
- The Pharmaceutical API market expanded in 2025, providing underlying support for Bupropion demand.
- Industrial production rose by 6.5% in September 2025, bolstering supply chain stability for Bupropion manufacturing.
- Retail sales grew by 3.0% in September 2025, indicating stable consumer spending power for medications.
- Persistent overcapacity in China's chemical industry during Q3 2025 influenced Bupropion supply and inventory.
- Natural gas prices stabilized in Q3 2025, contributing to stable energy costs for Bupropion production.
- The Manufacturing Index contracted in September 2025, signaling a broader slowdown affecting Bupropion's supply chain.
Why did the price of Bupropion change in September 2025 in APAC?
- Falling PPI (-2.3% in September 2025) reduced production costs, influencing Bupropion pricing.
- Pessimistic consumer confidence (89.6 in September 2025) tempered demand, impacting Bupropion price stability.
- Persistent chemical overcapacity in Q3 2025 contributed to ample supply, pressuring Bupropion prices.
Bupropio Prices in Europe
- In Germany, the Bupropion Price Index remained stable quarter-over-quarter in Q3 2025, reflecting balanced market dynamics.
- Bupropion production costs faced upward pressure from a 2.4% CPI in September 2025, increasing operational expenses.
- Conversely, a -1.7% PPI in September 2025 indicated lower producer input costs, easing Bupropion manufacturing expenses.
- The Bupropion demand outlook was supported by a low 3.9% unemployment rate in September 2025, bolstering consumer affordability.
- However, consumer confidence declined significantly by -23.6 index points in September 2025, posing a bearish demand outlook.
- High energy and raw material costs continued to burden the German chemical industry throughout Q3 2025, affecting Bupropion production.
- The Manufacturing Index contracting in September 2025, alongside a -1.0% industrial production decline, signaled broader economic slowdown.
- Bupropion price forecast suggests continued stability, as resilient pharmaceutical output balances general industrial weakness in Q3 2025.
Why did the price of Bupropion change in September 2025 in Europe?
- A -1.7% PPI in September 2025 indicated lower producer input costs, easing Bupropion production.
- High energy costs and a 2.4% CPI in September 2025 increased Bupropion operational burdens.
- Strong consumer affordability from a 3.9% unemployment rate balanced weak consumer confidence.
